SUTRO BIOPHARMA INC (STRO)

US8693671021 - Common Stock

3.42  0 (0%)

After market: 3.51 +0.09 (+2.63%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to STRO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 13.15. This target is 284.41% above the current price.
STRO was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about STRO.
In the previous month the buy percentage consensus was at a similar level.
STRO was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 3.428.0812.2413.1521.00 - 136.26% 257.89% 284.41% 514.04%
Up and Down Grades
Date Firm Action Rating
2024-04-03 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-04-03 Oppenheimer Maintains Outperform -> Outperform
2024-04-03 Truist Securities Maintains Buy -> Buy
2024-04-03 Piper Sandler Reiterate Overweight -> Overweight
2024-03-28 Oppenheimer Maintains Outperform -> Outperform
2024-03-27 Oppenheimer Maintains Outperform -> Outperform
2024-03-26 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-03-26 Wedbush Maintains Outperform -> Outperform
2024-03-26 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-15 Piper Sandler Maintains Overweight -> Overweight
2023-11-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-09 Deutsche Bank Initiate Buy
2023-10-23 Wedbush Reiterate Outperform -> Outperform
2023-10-06 Oppenheimer Initiate Outperform
2023-09-06 Truist Securities Reiterate Buy -> Buy
2023-08-14 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-08-11 Wedbush Maintains Outperform -> Outperform
2023-08-11 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-27 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-06-12 JMP Securities Reiterate Market Outperform
2023-05-17 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-05-16 HC Wainwright & Co. Reiterate Buy -> Buy
2023-04-03 JMP Securities Maintains Outperform
2023-03-31 Wedbush Reiterate Outperform
2023-03-31 HC Wainwright & Co. Maintains Buy
2023-01-13 Truist Securities Maintains Buy
2023-01-10 Piper Sandler Maintains Overweight
2022-11-09 HC Wainwright & Co. Maintains Buy
2022-08-23 Truist Securities Maintains Buy
2022-05-23 Piper Sandler Maintains Overweight